600211 Tibet Rhodiola Pharmaceutical Holding
- 35.72
- -0.07-0.20%
Tibet Rhodiola Pharmaceutical Holding News
Announcement on the results of judicial execution of shares held by shareholders holding more than 5% of the shares of Tibet Nordicon Pharmaceutical Co., Ltd.
Announcement of progress of Tibet Nordicang Pharmaceutical Co., Ltd. on judicial execution of some shares held by shareholders holding 5% or more of the company's shares
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on judicial execution of some shares held by shareholders holding 5% or more of the company's shares
Legal Opinion of the 2023 Annual General Meeting of Shareholders of Tibet Pharmaceutical
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Tibet Nordicang Pharmaceutical Co., Ltd.
Documents of the 2023 Annual General Meeting of Shareholders
An indicative announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. receiving industry support funds
Report on the performance of the Audit Committee for the year 2023
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on changes in accounting estimates
Constitution of Tibet Pharmaceutical Company (revised in March 2024)
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on revising the “Articles of Association” and some systems
Rules of procedure of the Tibet Pharmaceutical Board of Directors (revised in March 2024)
Board Secretary Work System (Revised in March 2024)
Implementation Rules for Audit Committee of the Board of Directors (Revised in March 2024)
Board Remuneration and Assessment Committee Implementation Rules (Revised in March 2024)
Independent Directors\' Annual Report Work System (Revised in March 2024)
Notice of Tibet Nordicang Pharmaceutical Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the use of idle funds for cash management
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on preparation for depreciation of accrued assets
Analysis
Price Target
No Data
